Literature DB >> 3181128

Kinetic parameters of the protein tyrosine kinase activity of EGF-receptor mutants with individually altered autophosphorylation sites.

A Honegger1, T J Dull, D Szapary, A Komoriya, R Kris, A Ullrich, J Schlessinger.   

Abstract

Epidermal growth factor (EGF)-receptor mutants in which individual autophosphorylation sites (Tyr1068, Tyr1148 or Tyr1173) have been replaced by phenylalanine residues were expressed in NIH-3T3 cells lacking endogenous EGF-receptors. Kinetic parameters of the kinase of wild-type and mutant receptors were compared. Both wild-type and mutant EGF-receptors had a Km(ATP) 1-3 microM for the autophosphorylation reaction, and a Km(ATP) of 3-7 microM for the phosphorylation of a peptide substrate. These are similar to the Km(ATP) values reported for EGF-receptor of A431 cells. A synthetic peptide representing the major in vitro autophosphorylation site Tyr1173 of the EGF-receptor (KGSTAENAEYLRV) was phosphorylated by wild-type receptor with a Km of 110-130 microM, and the peptide inhibited autophosphorylation with a Ki of 150 microM. Mutant EGF-receptors phosphorylated the peptide substrate with a Km of 70-100 microM. A similar decrease of Km (substrate) was obtained when the phosphorylation experiments were performed with the commonly applied substrates angiotensin II and a peptide derived from c-src. The Km of angiotensin II phosphorylation was reduced from 1100 microM for wild-type receptor to 890 microM for mutant receptor and for c-src peptide from 1010 microM to 770 microM respectively. The Vmax of the kinase was dependent on receptor concentration, but was not significantly affected by the mutation. Analogs of the Tyr1173 peptide in which the tyrosine residue was replaced by either a phenylalanine or an alanine residue also inhibited autophosphorylation with Ki of 650-750 microM. These analyses show that alterations of individual autophosphorylation sites do not have a major effect on kinase activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3181128      PMCID: PMC454692          DOI: 10.1002/j.1460-2075.1988.tb03170.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  22 in total

Review 1.  Molecular analysis of signal transduction by growth factors.

Authors:  Y Yarden; A Ullrich
Journal:  Biochemistry       Date:  1988-05-03       Impact factor: 3.162

2.  Interaction of epidermal growth factor-dependent protein kinase with endogenous membrane proteins and soluble peptide substrate.

Authors:  D Cassel; L J Pike; G A Grant; E G Krebs; L Glaser
Journal:  J Biol Chem       Date:  1983-03-10       Impact factor: 5.157

3.  Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbB protein.

Authors:  R M Kris; I Lax; W Gullick; M D Waterfield; A Ullrich; M Fridkin; J Schlessinger
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

4.  Phosphorylation activates the insulin receptor tyrosine protein kinase.

Authors:  O M Rosen; R Herrera; Y Olowe; L M Petruzzelli; M H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

5.  Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences.

Authors:  J Downward; Y Yarden; E Mayes; G Scrace; N Totty; P Stockwell; A Ullrich; J Schlessinger; M D Waterfield
Journal:  Nature       Date:  1984 Feb 9-15       Impact factor: 49.962

6.  Autophosphorylation sites on the epidermal growth factor receptor.

Authors:  J Downward; P Parker; M D Waterfield
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

7.  Immunoaffinity purification of the epidermal growth factor receptor. Stoichiometry of binding and kinetics of self-phosphorylation.

Authors:  W Weber; P J Bertics; G N Gill
Journal:  J Biol Chem       Date:  1984-12-10       Impact factor: 5.157

8.  Kinetic properties and sites of autophosphorylation of the partially purified insulin receptor from hepatoma cells.

Authors:  M F White; H U Haring; M Kasuga; C R Kahn
Journal:  J Biol Chem       Date:  1984-01-10       Impact factor: 5.157

9.  Epidermal growth factor stimulates the phosphorylation of synthetic tyrosine-containing peptides by A431 cell membranes.

Authors:  L J Pike; B Gallis; J E Casnellie; P Bornstein; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

10.  The kinetics of tyrosine phosphorylation by the purified epidermal growth factor receptor kinase of A-431 cells.

Authors:  C Erneux; S Cohen; D L Garbers
Journal:  J Biol Chem       Date:  1983-04-10       Impact factor: 5.157

View more
  39 in total

1.  Carboxyl-terminal deletion and point mutations decrease the transforming potential of the activated rat neu oncogene product.

Authors:  Y Mikami; J G Davis; K Dobashi; W C Dougall; J N Myers; V I Brown; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

2.  95-kilodalton B-Raf serine/threonine kinase: identification of the protein and its major autophosphorylation site.

Authors:  R M Stephens; G Sithanandam; T D Copeland; D R Kaplan; U R Rapp; D K Morrison
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

3.  The tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylation.

Authors:  L Naldini; E Vigna; R Ferracini; P Longati; L Gandino; M Prat; P M Comoglio
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

4.  Phosphorylation and activation of epidermal growth factor receptors in cells transformed by the src oncogene.

Authors:  W J Wasilenko; D M Payne; D L Fitzgerald; M J Weber
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

Review 5.  Structure and function of tyrosine kinase receptors.

Authors:  M F White
Journal:  J Bioenerg Biomembr       Date:  1991-02       Impact factor: 2.945

6.  Activation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants.

Authors:  L Varticovski; G Q Daley; P Jackson; D Baltimore; L C Cantley
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

7.  A transforming mutation enhances the activity of the c-Kit soluble tyrosine kinase domain.

Authors:  L P Lam; R Y Chow; S A Berger
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

8.  Disease tropism of c-erbB: effects of carboxyl-terminal tyrosine and internal mutations on tissue-specific transformation.

Authors:  R J Pelley; N J Maihle; C Boerkoel; H K Shu; T H Carter; C Moscovici; H J Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

9.  The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains.

Authors:  A D D'Andrea; A Yoshimura; H Youssoufian; L I Zon; J W Koo; H F Lodish
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

10.  In vitro enzymatic characterization of near full length EGFR in activated and inhibited states.

Authors:  Chen Qiu; Mary K Tarrant; Tatiana Boronina; Patti A Longo; Jennifer M Kavran; Robert N Cole; Philip A Cole; Daniel J Leahy
Journal:  Biochemistry       Date:  2009-07-21       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.